Lipid mediator dysregulation in primary pulmonary hypertension

被引:28
作者
Christman, BW [1 ]
机构
[1] Vanderbilt Univ, Ctr Lung Res, Nashville, TN 37232 USA
关键词
D O I
10.1378/chest.114.3_Supplement.205S
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
The characteristic arteriopathy of primary pulmonary hypertension (PPH) with attendant endothelial dysfunction provides an opportunity for enhanced cellular activation in the lung. Data from many laboratories support the concept of altered eicosanoid metabolism in PPH. Rigorously quantitative measurements of the excretion of metabolites of thromboxane A(2) and prostacyclin support persistent platelet activation and inadequate endothelial response in patients with PPH. Recent studies measuring excretion of prostaglandin D-2 metabolites suggest that additional cell sources, such as activated tissue macrophages, may also play a role in the observed elevation in thromboxane excretion and possibly in the pathogenesis of the vascular remodeling. Additional research examining in vivo cell activation in patients receiving therapy with long-term infusion of prostacyclin may further our understanding of the pathogenesis of PPH.
引用
收藏
页码:205S / 207S
页数:3
相关论文
共 16 条
[1]   DECREASED ARTERIAL-WALL PROSTAGLANDIN PRODUCTION IN NEONATAL CALVES WITH SEVERE CHRONIC PULMONARY-HYPERTENSION [J].
BADESCH, DB ;
ORTON, EC ;
ZAPP, LM ;
WESTCOTT, JY ;
HESTER, J ;
VOELKEL, NF ;
STENMARK, KR .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1989, 1 (06) :489-498
[2]   A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension [J].
Barst, RJ ;
Rubin, LJ ;
Long, WA ;
McGoon, MD ;
Rich, S ;
Badesch, DB ;
Groves, BM ;
Tapson, VF ;
Bourge, RC ;
Brundage, BH ;
Koerner, SK ;
Langleben, D ;
Keller, CA ;
Murali, S ;
Uretsky, BF ;
Clayton, LM ;
Jobsis, MM ;
Blackburn, SD ;
Shortino, D ;
Crow, JW .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (05) :296-301
[3]   11-DEHYDROTHROMBOXANE-B2 - A QUANTITATIVE INDEX OF THROMBOXANE-A2 FORMATION IN THE HUMAN CIRCULATION [J].
CATELLA, F ;
HEALY, D ;
LAWSON, JA ;
FITZGERALD, GA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (16) :5861-5865
[4]   AN IMBALANCE BETWEEN THE EXCRETION OF THROMBOXANE AND PROSTACYCLIN METABOLITES IN PULMONARY-HYPERTENSION [J].
CHRISTMAN, BW ;
MCPHERSON, CD ;
NEWMAN, JH ;
KING, GA ;
BERNARD, GR ;
GROVES, BM ;
LOYD, JE .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (02) :70-75
[5]  
FITZGERALD DJ, 1985, CIRCULATION S, V72, P111
[6]  
JONES DA, 1993, J BIOL CHEM, V268, P9049
[7]   Low-affinity thromboxane receptor mediates proliferation in cultured vascular smooth muscle cells of rats [J].
Ko, FN .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (07) :1274-1282
[8]   HETEROGENEITY OF PATHOLOGIC LESIONS IN FAMILIAL PRIMARY PULMONARY-HYPERTENSION [J].
LOYD, JE ;
ATKINSON, JB ;
PIETRA, GG ;
VIRMANI, R ;
NEWMAN, JH .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1988, 138 (04) :952-957
[9]  
MEHTA JL, 1997, ENDOTHELIUM CLIN PRA, P45
[10]  
MIZUNOYAGYU Y, 1987, BIOCHEM PHARMACOL, V36, P3808